MeBIO

CAS No. 667463-95-8

MeBIO( —— )

Catalog No. M27489 CAS No. 667463-95-8

MeBIO is an agonist of aryl hydrocarbon receptor, with IC50 of 44 and 55 μM for GSK-3 and CDK1/CyclinB, respectively. MeBIO does not affect GSK-3β.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 61 Get Quote
10MG 107 Get Quote
25MG 209 Get Quote
50MG 336 Get Quote
100MG 492 Get Quote
500MG 1071 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MeBIO
  • Note
    Research use only, not for human use.
  • Brief Description
    MeBIO is an agonist of aryl hydrocarbon receptor, with IC50 of 44 and 55 μM for GSK-3 and CDK1/CyclinB, respectively. MeBIO does not affect GSK-3β.
  • Description
    MeBIO is an agonist of aryl hydrocarbon receptor, with IC50 of 44 and 55 μM for GSK-3 and CDK1/CyclinB, respectively. MeBIO does not affect GSK-3β.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    DHODH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    667463-95-8
  • Formula Weight
    370.2
  • Molecular Formula
    C17H12BrN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 14.71 mg/mL (39.74 mM)
  • SMILES
    CN(c(cc(cc1)Br)c1/C1=C2/Nc(cccc3)c3/C2=N\O)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Scott Kuduk, et al. Dihydroorotate dehydrogenase inhibitors. WO2020212897A1.
molnova catalog
related products
  • A 1070722

    A 1070722 is a potent and selective GSK-3 inhibitor, shows high affinity GSK-3α(Ki = 0.6 nM) and GSK-3β(Ki = 0.6 nM).

  • AZD2858

    AZD2858 is a selective GSK-3 inhibitor with an IC50 of 68 nM, inhibits tau phosphorylation at the S396 site, activates Wnt signaling pathway.

  • TDZD-8

    A potent, selective, non-ATP competitive GSK-3β inhibitor with IC50 of 2 uM; displays no activity against PKA, CK-2, PKC, and CDK1 (IC50>100 uM).